1 Emory E, Pattillo D, Archibald E, Bayroh M, Sung F. Neurobehavioral effects of low-level lead exposure in human neonates. Am J Obstet Synecol 1999;181:S2-S11
2 Lanphear BP, Dietrich K, Auinger P, Cox C. Subclinical lead toxicity in U.S. children and adolescents [abstract #894]. APS/SPR Joint Meeting; 2000 May 12-16;Boston MA.
3 Wilson MA, Johnston MV, Goldstein GW, Blue ME. Neonatal lead exposure impairs development of rodent barrel field cortex. PNAS 2000;97(10):5540-5545.
4 Edelson SB, Cantor DS. Autism: Xenobiotic influences. Toxicology and industrial health 1998;14(4):553-563.
5 Autism: a unique form of mercury poisoning. Available at the Cure Autism Now Foundation website: http://www.canfoundation.org/newcansite/sciwatch/invest.html
6 Halsey NA. Limiting infant exposure to thimerosal in vaccines and other sources of mercury. JAMA. 1999 Nov 10;282(18):1763-6.
7 Cohen DJ, Johnson WT, Caparulo BK. Pica and elevated blood lead level in autistic and atypical children. Am J Dis Child 1976;130(1):47-48.
8 Accardo P, Whitman B, Caul J, Rolfe U. Autism and plumbism. A possible association. Clin Pediatr 1988;27(1):41-4.
9 Shannon M, Graef Jw. Lead intoxication in children with pervasive developmental disorders. J Toxicol Clin Toxicol 1996;34(2):177-81.
10 Tuthill RW. Hair lead levels related to childrenÕs classroom attention-deficit behavior. Arch Environ Health 1996;51(3):214-220.
11 Wecker L, Miller SB, Cochran SR, Dugger DL, Johnson WD. Trace element concentrations in hair from autistic children. J Ment Defic Res 1985;15-22.
12 Kozielec T, Starobrat-Hermelin B. Assessment of magnesium levels in children with attention deficit hyperactivity disorder (ADHD). Magnes Res;1997 Jun;10(2):143-8
13 Rimland B. Controversies in the treatment of autistic children: vitamin and drug therapy. J Child Neurol 1988;3 Suppl:S68-72.
14 Findling RL, Maxwell K, Scoteses-Wojtila L, Huang J, Yamashita T, Wiznitzer M. High-dose pyridoxine and magnesioum administration in children with autistic disorder: an absence of salutary effects in a double-blink, placebo-controlled study. J Aut Dev Disord 1997;27(4): 467-78.